Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin

Currently, hyperlipidemia is a growing health issue that is considered a risk factor for obesity. Controlling body weight and modifying life style in most of cases are not adequate and the condition requires medical treatment. Statin drugs (mainly Atorvastatin (ATO)), have been used broadly and for...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsewedy, Heba S., Shehata, Tamer M., Almostafa, Mervt M., Soliman, Wafaa E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267979/
https://www.ncbi.nlm.nih.gov/pubmed/35807995
http://dx.doi.org/10.3390/nano12132160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267979/
https://www.ncbi.nlm.nih.gov/pubmed/35807995
http://dx.doi.org/10.3390/nano12132160

Ejemplares similares